raloxifene hydrochloride has been researched along with Blast Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, R; Del Mar, NA; Henderson, DL; Honig, MG; Li, C; Moore, BM; O'Neal, D; Perry, AM; Reiner, A; Yammanur, M | 1 |
1 other study(ies) available for raloxifene hydrochloride and Blast Injuries
| Article | Year |
|---|---|
Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast.
Topics: Animals; Blast Injuries; Cannabinoid Receptor Agonists; Cannabinoids; Eye Injuries; Mice; Mice, Inbred C57BL; Microglia; Raloxifene Hydrochloride | 2022 |